TRIPALDELLA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 179
EU - Europa 118
AS - Asia 53
AF - Africa 5
OC - Oceania 1
Totale 356
Nazione #
US - Stati Uniti d'America 178
IT - Italia 69
SG - Singapore 30
IN - India 18
GB - Regno Unito 13
UA - Ucraina 13
DE - Germania 6
NL - Olanda 6
CI - Costa d'Avorio 5
CN - Cina 4
CH - Svizzera 3
FR - Francia 3
FI - Finlandia 2
IE - Irlanda 2
AU - Australia 1
CA - Canada 1
CZ - Repubblica Ceca 1
JP - Giappone 1
Totale 356
Città #
Chandler 37
Naples 36
Ashburn 32
Singapore 27
Boardman 10
Lawrence 9
Napoli 7
Santa Clara 7
Amsterdam 6
Millbury 6
Boston 4
Washington 4
Wilmington 4
Des Moines 3
Magenta 3
Pune 3
Zurich 3
Cercola 2
Delhi 2
Dublin 2
Lappeenranta 2
London 2
Torre Del Greco 2
Abidjan 1
Castellammare Di Stabia 1
Cava de' Tirreni 1
Council Bluffs 1
Freiburg im Breisgau 1
Hangzhou 1
Jinan 1
Los Angeles 1
Milan 1
Munich 1
Osaka 1
Prague 1
Rome 1
Sciacca 1
Shanghai 1
Trecase 1
Urgnano 1
Woodbridge 1
Totale 231
Nome #
Dyslipidemia in Transplant Patients: Which Therapy? 54
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab 54
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 40
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. 38
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 35
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 31
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 30
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 25
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach 25
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 22
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 15
Totale 369
Categoria #
all - tutte 1.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 5 2 2 0 0 0 0 0
2020/20217 0 0 1 1 1 0 1 0 0 1 0 2
2021/202287 0 4 2 0 2 1 1 5 3 11 45 13
2022/2023102 9 6 6 8 10 15 1 14 17 8 6 2
2023/2024107 11 8 4 7 7 26 0 6 14 3 5 16
2024/202557 25 9 6 11 6 0 0 0 0 0 0 0
Totale 369